Editas

Blood & Organ Banks · Massachusetts, United States · 51-200 Employees

View Company Info for Free

Overview

Headquarters

11 Hurley St, Cambridge, Massachusetts, ...

Phone Number

(617) 401-9000

Revenue

$47 Million

Stock Symbol

EDIT

Industry

Blood & Organ Banks Business Services Healthcare Services Research & Development

About Editas

Editas Medicine is a leading gene editing company dedicated to developing CRISPR medicines for individuals with serious diseases. The company aims to harness the potential of CRISPR technology to create transformative genomic medicines that can address a wide range of health conditions. Their mission is to discover, develop, manufacture, and commercialize these innovative treatments for patients globally. Editas Medicine is committed to delivering durable solutions to improve the lives of those affected by serious illnesses.Explore more
Editas's Social MediaSIC Code 28,283NAICS Code 32,325Ticker NASDAQ: EDITShow more

Editas Org Chart

Gilmore O’Neill, President & Chief Executive Officer at Editas
United States flag for contact location.

President & Chief Executive Officer

PhoneEmail
AP
United States flag for contact location.

Senior Vice President & Chief Financial Offic...

PhoneEmail
Preethi Bapna, Vice President, Corporate Strategy & Communications To The Chief of Staff & Chief Executive Officer at Editas
United States flag for contact location.

Vice President, Corporate Strategy & Communic...

PhoneEmail
Daniel Ory, Executive, VP & Chief Medical Officer at Editas
United States flag for contact location.

Executive, VP & Chief Medical Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
SD
United States flag for contact location.

Vice President, Financial Planning Analysis

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to Editas

Compare insights from companies similar to Editas, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Editas

$47M
51-200
Public
$257.4M
2013
Gilmore O’Neill, President & Chief Executive Officer at Editas
Gilmore O’NeillPresident & CEO
$66.4M
51-200
Private
$25M
2008
Timothy Largen, Chief Operating Officer at Applied Stemcell
Timothy LargenChief Operating Officer
$45.1M
51-200
Public
$321M
2006
Naresh Tanna, Chief Financial Officer at Precision BioScience
Naresh TannaChief Financial Officer
$42.3M
51-200
Private
$467.6M
2012
GH
Gregory HuegerichVice President, Marketing
$39.6M
51-200
Public
$374.6M
1995
PR
Phillip RamseyChief Technical Officer
$29.6M
51-200
Private
$417.5M
2015
AA
Atulya AgarwalChief Legal Officer
$20.5M
51-200
Private
$456M
2015
Michael Curtis, President & Chief Executive Officer at eGenesis
Michael CurtisPresident & CEO
Illustration of an envelope

Editas Tech Stack

Top Blood & Organ Banks Companies

Frequently Asked Questions Regarding Editas

What is Editas's stock symbol?
Editas's stock symbol is EDIT
What is Editas's official website?
Editas's official website is www.editasmedicine.com
What is Editas's Revenue?
Editas's revenue is $47 Million
What is Editas's SIC code?
Editas's SIC: 28,283
What is Editas's NAICS code?
Editas's NAICS: 32,325
How many employees does Editas have?
Editas has 51-200 employees
What industry does Editas belong to?
Editas is in the industry of: Blood & Organ Banks, Business Services, Healthcare Services
What is Editas competition?
Editas top competitors include: Synthego, Applied Stemcell, Precision BioScience, Inscripta
What technology does Editas use?
Some of the popular technologies that Editas uses are: WordPress.org, PHP, Cloudflare Website Optimization, Google Universal Analytics
Who is the CFO of Editas?
Editas's CFO is Amy Parison
How do I contact Editas?
Editas contact info: Phone number: (617) 401-9000 Website: www.editasmedicine.com
What does Editas do?

Editas Medicine is a leading gene editing company dedicated to developing CRISPR medicines for individuals with serious diseases. The company aims to harness the potential of CRISPR technology to create transformative genomic medicines that can address a wide range of health conditions. Their mission is to discover, develop, manufacture, and commer... cialize these innovative treatments for patients globally. Editas Medicine is committed to delivering durable solutions to improve the lives of those affected by serious illnesses.Read More

What are Editas social media links?
Editas Linkedin page Editas Twitter page Editas Facebook page
Who invested in Editas?
Editas has 22 investors including Polaris Partners, Flagship Pioneering, Partners Innovation Fund and Third Rock Ventures.
Is Editas a public company?
Yes, Editas is a public company and is traded under the symbol EDIT
See more information about Editas

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.